UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autoimmune cytopenia and CLL ride together

Blood, 2021-06, Vol.137 (25), p.3464-3465

Moreno, Carol

2021

Volltextzugriff (PDF)

MRD in CLL: some answers, many questions

Blood, 2021-12, Vol.138 (26), p.2746-2747

2021

Volltextzugriff (PDF)

Chronic lymphocytic leukemia and the Warburg effect

Blood, 2015-05, Vol.125 (22), p.3368-3369

Moreno, Carol

2015

Volltextzugriff (PDF)

Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab

Blood, 2019-05, Vol.133 (19), p.2031-2042

2019

Volltextzugriff (PDF)

High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies

Blood, 2018-08, Vol.132 (9), p.892-902

2018

Volltextzugriff (PDF)

Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma

Blood, 2016-11, Vol.128 (18), p.2241-2252

2016

Volltextzugriff (PDF)

Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?

Blood, 2014-12, Vol.124 (26), p.3841-3849

2014

Volltextzugriff (PDF)

Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group

Blood, 2019-11, Vol.134 (Supplement_1), p.4910-4910

2019

Volltextzugriff (PDF)

Lessons Learned from Shared Decision Making with Oral Anticoagulants: A Literature Review and Evidence-Based Guide for Development of Oral Chemotherapy Decision Aids

Blood, 2023-11, Vol.142 (Supplement 1), p.7207-7207

2023

Volltextzugriff (PDF)

Shared Decision-Making Aids for Pediatric Chronic Hematological and Non-Hematological Conditions: An in-Depth Literature Review

Blood, 2023-11, Vol.142 (Supplement 1), p.7212-7212

2023

Volltextzugriff (PDF)

Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

Blood, 2021-04, Vol.137 (14), p.1879-1894

2021

Volltextzugriff (PDF)

Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism

Blood, 2011-05, Vol.117 (20), p.5372-5380

2011

Volltextzugriff (PDF)

Single Cell Multi-Omic Analysis of Tumor Microenvironment Evolution across the Disease Spectrum of Multiple Myeloma Identifies Differential Mechanisms of Immune Suppression

Blood, 2023-11, Vol.142 (Supplement 1), p.89-89

2023

Volltextzugriff (PDF)

A Real-World Analysis of Immune Thrombotic Thrombocytopenic Purpura: Comparing Clinical Outcomes of Conventional Treatment Vs Addition of Caplacizumab, a Single-Center Experience

Blood, 2023-11, Vol.142 (Supplement 1), p.2634-2634

2023

Volltextzugriff (PDF)

Prenatal Inflammation Promotes Enhanced Allergic Lung Inflammation By Programming Hyperactive ILC2s from Fetal Hematopoietic Progenitors

Blood, 2023-11, Vol.142 (Supplement 1), p.3924-3924

2023

Volltextzugriff (PDF)

A Case Report of a Patient with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan Who Underwent Major Surgery

Blood, 2023-11, Vol.142 (Supplement 1), p.5656-5656

2023

Volltextzugriff (PDF)

IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL

Blood, 2003-08, Vol.102 (3), p.1078-1086

2003

Volltextzugriff (PDF)

Excess in Atherosclerotic and Inflammametabolic Diseases Are Differentially Expressed in Myelodysplasia and Are Highly Dependent on Age, R-IPSS and Ethnicity

Blood, 2018-11, Vol.132 (Supplement 1), p.4855-4855

2018

Volltextzugriff (PDF)

Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort

Blood, 2022-06, Vol.139 (22), p.3278-3289

2022

Volltextzugriff (PDF)

Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance

Blood, 2010-12, Vol.116 (23), p.4771-4776

2010

Volltextzugriff (PDF)

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

Blood, 2024-08, Vol.144 (6), p.646-656

2024

Volltextzugriff (PDF)

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study

Blood, 2022-11, Vol.140 (Supplement 1), p.9908-9910

2022

Volltextzugriff (PDF)

Clinical Features and Diagnostic Delay of Tuberculosis (TB) in Patients with Acute Myeloid Leukemia. (AML)

Blood, 2019-11, Vol.134 (Supplement_1), p.5114-5114

2019

Volltextzugriff (PDF)

Expansion, Persistence and Pharmacodynamic Profile of ADI-001, a First-in-Class Allogeneic CD20-Targeted CAR Gamma Delta T Cell Therapy, in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Blood, 2023-11, Vol.142 (Supplement 1), p.3478-3478

2023

Volltextzugriff (PDF)

1 – 25 von 455

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(455)
Mit Volltextzugriff
(451)

Publikationsform

Artikel
(455)

Sprache

Englisch
(455)

Erscheinungsjahr

n.n

Thema

Hematology
(75)
Life Sciences & Biomedicine
(73)
Science & Technology
(73)
Humans
(68)
Biological And Medical Sciences
(45)
Medical Sciences
(39)
Hematologic And Hematopoietic Diseases
(29)
Male
(27)
Female
(24)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(23)
Middle Aged
(22)
Aged
(17)
Animals
(17)
Prognosis
(16)
Adult
(14)
Mice
(13)
Lymphoid Neoplasia
(11)
Cell Line, Tumor
(9)
Follow-Up Studies
(9)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(9)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Blood-The Journal Of Hematology
(1)

Menü

Weitere Dienste

Einstellungen

Autoimmune cytopenia and CLL ride together

MRD in CLL: some answers, many questions

Chronic lymphocytic leukemia and the Warburg effect

Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab

High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies

Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma

Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?

Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group

Lessons Learned from Shared Decision Making with Oral Anticoagulants: A Literature Review and Evidence-Based Guide for Development of Oral Chemotherapy Decision Aids

Shared Decision-Making Aids for Pediatric Chronic Hematological and Non-Hematological Conditions: An in-Depth Literature Review

Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism

Single Cell Multi-Omic Analysis of Tumor Microenvironment Evolution across the Disease Spectrum of Multiple Myeloma Identifies Differential Mechanisms of Immune Suppression

A Real-World Analysis of Immune Thrombotic Thrombocytopenic Purpura: Comparing Clinical Outcomes of Conventional Treatment Vs Addition of Caplacizumab, a Single-Center Experience

Prenatal Inflammation Promotes Enhanced Allergic Lung Inflammation By Programming Hyperactive ILC2s from Fetal Hematopoietic Progenitors

A Case Report of a Patient with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan Who Underwent Major Surgery

IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL

Excess in Atherosclerotic and Inflammametabolic Diseases Are Differentially Expressed in Myelodysplasia and Are Highly Dependent on Age, R-IPSS and Ethnicity

Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort

Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance

ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study

Clinical Features and Diagnostic Delay of Tuberculosis (TB) in Patients with Acute Myeloid Leukemia. (AML)

Expansion, Persistence and Pharmacodynamic Profile of ADI-001, a First-in-Class Allogeneic CD20-Targeted CAR Gamma Delta T Cell Therapy, in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Aktive Filter

Suchergebnisse filtern